pharma

Carbomer homopolymer type b (allyl pentaerythritol crosslinked)

CAS 151687-96-6

Also registered as 1 other CAS number

9007-20-9

Concern score

Not assessed — no hazard data yet.

Carbomer homopolymer type b (allyl pentaerythritol crosslinked) in plain language

What it is: Also known as Carbomer 974 · Carbomer homopolymer type b · Carbomer 934P (allyl pentaerythritol crosslinked) · Carbomer 974 (p) · Carbopol 974 · Carbopol 974P
What it does: We don't have a plain-language description for Carbomer homopolymer type b (allyl pentaerythritol crosslinked) yet.
Is it a concern?: We haven't assessed a concern score for this ingredient yet.

Regulation

No restrictions found. Carbomer homopolymer type b (allyl pentaerythritol crosslinked) appears in these published regulatory listings.

Inactive ingredient in US drugs

USFDAinactive ingredient database17 entries — 6 administration routes
- Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 19 mgSource →
- Route: OPHTHALMIC; Dosage form: GEL; Maximum daily exposure: 2 mgSource →
- Route: OPHTHALMIC; Dosage form: SUSPENSION; Maximum daily exposure: 1 mgSource →
- Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 0.45 %w/vSource →
- Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 50 mgSource →
- Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 600 mgSource →
- Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 64 mgSource →
- Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 8 mgSource →
- Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 180 mgSource →
- Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 214 mgSource →
- Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 81 mgSource →
- Route: TOPICAL; Dosage form: LOTION; Potency: 0.3 %w/wSource →
- Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 11 mgSource →
- Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 11 mgSource →
- Route: TOPICAL; Dosage form: SUSPENSION/ DROPS; Potency: 0.4 %w/vSource →
- Route: TRANSDERMAL; Dosage form: GEL; Maximum daily exposure: 19 mgSource →
- Route: VAGINAL; Dosage form: GEL; Maximum daily exposure: 200 mgSource →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as polymer.
- openFDA substance registry classifies this ingredient as polymer.Source →

Evidence & sources

No graded research studies for Carbomer homopolymer type b (allyl pentaerythritol crosslinked) yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.

3 data sources

Where this comes from

FDA Inactive Ingredient Database
regulatory · updated 2026-01-09
Open →
FDA GSRS UNII
registry · updated 2026-02-26
Open →
openFDA Substance
registry · updated 2026-05-24
Open →

Reference links (1)

Openfda substance

aidsinfo.nih.gov

Read →

Suitability

Context-specific fit derived from published classifications and the current ingredient evidence profile.

Fragrance avoidance

Nothing to weigh for this context yet.

No signal in this context

We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.

Catalog

Found in these products

Their ingredient lists include Carbomer homopolymer type b (allyl pentaerythritol crosslinked); each product's own rating depends on its whole formula, so it is shown on the product page, not here.

See all 2 →Find products without it →